Susceptibility and outcome in MS: Associations with polymorphisms in pigmentation-related genes

Neurology

Volumn 62, Issue 12, 2004, Pages 2323-2325

  Partridge, J M ^a   Weatherby, S J M ^a   Woolmore, J A ^a   Highland, D J ^a   Fryer, A A ^a   Mann, C L A ^a   Boggild, M D ^c   Ollier, W E R ^b   Strange, R C ^a   Hawkins, C P ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HISTIDINE; MELANOCORTIN 1 RECEPTOR; MONOPHENOL MONOOXYGENASE; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PIGMENTATION; PRIORITY JOURNAL;

EID: 2942711624     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.12.2323     Document Type: Article

References (10)

1. Sawcer S, Robertson N, Compston A. Genetic epidemiology of multiple sclerosis. In: Thompson AJ, Polman C, Hohlfeld R, eds. Multiple sclerosis; clinical challenges and controversies. London: Martin Dunitz, 1997:13-34.
2. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-568.
3. Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997;216:21-27.
4. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr Scand 1960;35:132-147.
5. van der Mei IAF, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J 2003;327:316-322.
6. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1:74-76.
7. Luscombe CJ, French ME, Liu S, et al. Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br J Cancer 2001;85:1504-1509.
8. Perneger TV. What's wrong with Bonferroni adjustments. Br Med J 1998;316:1236-1238.
9. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93:7861-7864.
10. Luscombe CJ, Fryer AA, French ME, et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001;358:641-642.